Verrill Dana and Navigant Present: A Fitness Check for Mobile Technology Trials: Select Challenges & Pitfalls

April 28, 2017 at 9:30am11:00am (EST)
MassBio Collaboration Room

300 Technology Square

8th Floor

Cambridge, MA 02139

In response to the growing number of clinical trials investigating or incorporating mobile technologies, Verrill Dana and Navigant Consulting will host, "A Fitness Check for Mobile Technology Trials: Select Challenges & Pitfalls," on Friday, April 28 from 9:30 to 11:00am at MassBio.

During the complimentary presentation, Verrill Dana attorneys Emily Chi Fogler and Andrew Rusczek, and Navigant Consulting Director Scott Thiel, will describe select key challenges and pitfalls associated with the use of mobile technologies that can delay, derail, or undermine a trial, including challenges from regulatory, industry, and institutional perspectives. The speakers will discuss strategies for addressing these challenges.

"Issues such as data reliability, privacy, and human subject protections arise in all clinical research, but they have unique application in the context of mobile apps, sensors, and the like, given the power of these technologies to capture new forms of personal data," explained Fogler. "Anticipating and addressing these issues is critical to avoid jeopardizing a company's or institution's investment in a trial that relies on these technologies."

Find more information about the event and RSVP online here.

Firm Highlights


Hospital Price Transparency Rule: Full Steam Ahead

Neither COVID-19 nor continued legal challenges appear likely to derail the Centers for Medicare & Medicaid Services ( CMS) Hospital Price Transparency Rule from going into effect on January 1, 2021. Hospitals therefore should...


EU-U.S. Privacy Shield Invalidated: Does Your Company Have a Plan B?

On Thursday, July 16, 2020, the Court of Justice of the European Union (“CJEU”) invalidated the EU-U.S. Privacy Shield (“Privacy Shield”) in Data Protection Commissioner v. Facebook Ireland and Maximillian Schrems (Case C-311/18...


European Union GDPR—Institution

Counseled a preeminent health system and academic medical center on its compliance with the European Union General Data Protection Regulation (GDPR) in relation to its clinical and research activities, including its international research studies...


Michael K. Fee to Lead Verrill’s Nationally-Recognized Health Care and Life Sciences Practice Amidst Recent Changes

(August 31, 2020) – Verrill is pleased to announce Michael K. Fee as the new leader of Verrill’s nationally-recognized Health Care & Life Sciences Group. The Group has a long history of representing a...


Common Rule

Guided multiple clients through the implementation of the revised HHS regulations (the "Common Rule"), including reviewing and revising policies and procedures, and assisting with institutional approaches to implementation.


“If I've told you once, I've told you eight times…” HHS OIG Issues Another Audit Report on Hospitals’ Failure to Report Credits for Explanted Cardiac Devices and Lays the Groundwork Collection of Overpayments


Nearly 80 Verrill Attorneys Recognized by Best Lawyers® 2021, Including a Dozen Named Lawyers of the Year

(August 24, 2020) – Nearly 80 Verrill attorneys were recognized as "Best Lawyers" by Best Lawyers® 2021 , including 12 attorneys named “Lawyer of the Year,” a distinguished recognition for only a single lawyer...


News Flash: HHS Issues Statement Removing Premarket Review Requirements for Laboratory Developed Tests (“LDTs”), Including COVID-19 LDTs

What happened? On August 19, 2020, the U.S. Department of Health and Human Services (“HHS”) issued a single paragraph statement rescinding U.S. Food and Drug Administration (“FDA”) guidance documents concerning premarket review of Laboratory...


Multi-Site Global Research

Developed and negotiated site and coordinating center agreements in connection with a multi-site, international, National Institutes of Health (NIH)-funded study, and advised on regulatory issues related to the conduct of the study and subsequent...


Conflicts of Interest

Reviewed medical center's systems, policies and procedures for identifying, assessing, and managing investigator and institutional conflicts of interest.

Contact Verrill at (855) 307 0700